zonisamide · Azurity · NDA 214273
Zonisade
Earliest generic entry, as listed
18 Aug 2038
Blocked by patent: US 11478456, US 11529333, US 12491179, US 12685723.
Listed patents · 4 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11478456 | use U-3458 · sets the listed date | 18 Aug 2038 |
| US 11529333 | drug product · sets the listed date | 18 Aug 2038 |
| US 12491179 | drug product · sets the listed date | 18 Aug 2038 |
| US 12685723 | drug product · sets the listed date | 18 Aug 2038 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214273 · 001 · RLD | suspension, oral | 100MG/5ML | 18 Aug 2038 |